CLINICAL_TRIALS
trial_result
· 2016-07-20
Clinical Trial Update: Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin [Phase 3]
Summary
A Phase 3 trial evaluating autologous transplantation of melanocytes for vitiligo has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Royan Institute | Conditions: Vitiligo | Phase 3 | Status: COMPLETED